|
Volumn 55, Issue 4, 2014, Pages 396-404
|
Plasminogen activator inhibitor-1 (PAI-1) molecule: new physiological roles and clinical applications.
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5-CHLORO-2-(((2-(4-(DIPHENYLMETHYL)PIPERAZIN-1-YL)-2-OXOETHOXY)ACETYL)AMINO)BENZOATE;
4 AMINOBENZOIC ACID DERIVATIVE;
5 CHLORO 2 (((2 (4 (DIPHENYLMETHYL)PIPERAZIN 1 YL) 2 OXOETHOXY)ACETYL)AMINO)BENZOATE;
FIBRINOLYTIC AGENT;
PIPERAZINE DERIVATIVE;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
AGING;
ANGIOGENESIS;
ANIMAL;
BLOOD CLOTTING;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
DRUG DEVELOPMENT;
GENETICS;
HUMAN;
INFLAMMATION;
LUNG FIBROSIS;
MOLECULARLY TARGETED THERAPY;
MOUSE;
PHYSIOLOGY;
RAT;
REGENERATION;
REVIEW;
THROMBOSIS;
AGING;
ANIMALS;
BLOOD COAGULATION;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DRUG DISCOVERY;
FIBRINOLYTIC AGENTS;
HUMANS;
INFLAMMATION;
MICE;
MOLECULAR TARGETED THERAPY;
NEOVASCULARIZATION, PHYSIOLOGIC;
PARA-AMINOBENZOATES;
PIPERAZINES;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PULMONARY FIBROSIS;
RATS;
REGENERATION;
THROMBOSIS;
|
EID: 84906097729
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|